Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer

Cancer treatment is evolving towards therapies targeted at specific molecular abnormalities that drive tumor growth. Consequently, to determine which patients are eligible, accurate assessment of molecular aberrations within tumors is required. Obtaining sufficient tumor tissue for molecular testing...

Descripción completa

Detalles Bibliográficos
Autores principales: Normanno, Nicola, Denis, Marc G., Thress, Kenneth S., Ratcliffe, Marianne, Reck, Martin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355360/
https://www.ncbi.nlm.nih.gov/pubmed/27980215
http://dx.doi.org/10.18632/oncotarget.13915

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5355360/
https://www.ncbi.nlm.nih.gov/pubmed/27980215
http://dx.doi.org/10.18632/oncotarget.13915

Ejemplares similares